Delivery Order SPE2DB20D7059-SPE2DB24FPXK2
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $16,351.77, is a delivery order for the supply of Bupropion HCL XL 300 mg tablets. The award has a period of performance through February 1, 2024 and utilizes a firm-fixed price pricing structure. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This contract award, valued at $29,606.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,323,524 units of Bupropion HCL XL 300 mg tablets, with a completion date of January 16, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $34,961.14, is for the delivery of Bupropion HCL XL 300 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract was awarded on February 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The $1,360.19 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of October 14, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medical products to federal agencies, primarily supporting the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $63,780.64, for the supply of 4564416340 - Bupropion HCL XL 300 MG Tablets in quantities of 500s. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,583.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Bupropion HCL XL 300 mg Tablets, with an ultimate completion date of November 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $28,378.07, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are registered as for-profit...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.92, is a firm fixed-price delivery order for the supply of 4565058004 - Bupropion HCL XL 300 mg Tablets in 500 count bottles. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,311,946 units of the pharmaceutical product Bupropion HCl XL 300 mg Tablet. The contract has a ceiling value of $36,539.49 and a period of performance through April 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive...